Segment Information (Tables)
|
12 Months Ended |
Dec. 31, 2022 |
Segment Reporting [Abstract] |
|
Schedule of Segment Reporting Information, by Segment |
The following table summarizes select operating results for each reportable segment (in millions).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor |
|
|
Predecessor |
(In millions) |
For Year Ended December 31, 2022 |
|
From October 20, 2021 through December 31, 2021 |
|
|
From July 1, 2021 through October 19, 2021 |
|
For Year Ended June 30. 2021 |
|
For Year Ended June 30, 2020 |
Revenues |
|
|
|
|
|
|
|
|
|
|
Medical |
$ |
271.7 |
|
|
$ |
49.2 |
|
|
|
$ |
60.3 |
|
|
$ |
155.7 |
|
|
$ |
62.6 |
|
Industrial |
446.1 |
|
|
104.9 |
|
|
|
107.7 |
|
|
455.9 |
|
|
415.6 |
|
Consolidated Revenues |
$ |
717.8 |
|
|
$ |
154.1 |
|
|
|
$ |
168.0 |
|
|
$ |
611.6 |
|
|
$ |
478.2 |
|
Segment (Loss) Income from Operations |
|
|
|
|
|
|
|
|
|
|
Medical |
$ |
(84.4) |
|
|
$ |
(4.3) |
|
|
|
$ |
0.7 |
|
|
$ |
6.0 |
|
|
$ |
13.9 |
|
Industrial |
(98.0) |
|
|
1.1 |
|
|
|
11.7 |
|
|
81.5 |
|
|
59.6 |
|
Total Segment (Loss) Income from Operations |
(182.4) |
|
|
(3.2) |
|
|
|
12.4 |
|
|
87.5 |
|
|
73.5 |
|
Corporate and other |
(115.4) |
|
|
(19.7) |
|
|
|
(54.0) |
|
|
(76.3) |
|
|
(50.5) |
|
Consolidated (Loss) Income from Operations |
$ |
(297.8) |
|
|
$ |
(22.9) |
|
|
|
$ |
(41.6) |
|
|
$ |
11.2 |
|
|
$ |
23.0 |
|
Capital Expenditures |
|
|
|
|
|
|
|
|
|
|
Medical |
$ |
22.6 |
|
|
$ |
3.8 |
|
|
|
$ |
6.8 |
|
|
$ |
14.2 |
|
|
$ |
10.1 |
|
Industrial |
11.6 |
|
|
2.0 |
|
|
|
2.7 |
|
|
12.2 |
|
|
11.4 |
|
Total operating and reportable segments |
34.2 |
|
|
5.8 |
|
|
|
9.5 |
|
|
26.4 |
|
|
21.5 |
|
Corporate and other |
0.4 |
|
|
0.3 |
|
|
|
0.3 |
|
|
— |
|
|
0.4 |
|
Total Capital Expenditures |
$ |
34.6 |
|
|
$ |
6.1 |
|
|
|
$ |
9.8 |
|
|
$ |
26.4 |
|
|
$ |
21.9 |
|
Depreciation and Amortization |
|
|
|
|
|
|
|
|
|
|
Medical |
$ |
82.4 |
|
|
$ |
17.0 |
|
|
|
$ |
13.3 |
|
|
$ |
33.3 |
|
|
$ |
15.8 |
|
Industrial |
91.1 |
|
|
20.1 |
|
|
|
12.4 |
|
|
49.7 |
|
|
52.2 |
|
Total operating and reportable segments |
173.5 |
|
|
37.1 |
|
|
|
25.7 |
|
|
83.0 |
|
|
68.0 |
|
Corporate and other |
1.0 |
|
|
0.2 |
|
|
|
0.2 |
|
|
0.6 |
|
|
0.4 |
|
Total Depreciation and Amortization |
$ |
174.5 |
|
|
$ |
37.3 |
|
|
|
$ |
25.9 |
|
|
$ |
83.6 |
|
|
$ |
68.4 |
|
|
Revenue from External Customers by Geographic Areas |
The following details revenues by geographic region. Revenues generated from external customers are attributed to geographic regions through sales from site locations (i.e., point of origin) (in millions).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
Successor |
|
|
Predecessor |
|
Fiscal Year Ended December 31, |
|
From October 20, 2021 through December 31 |
|
|
From July 1, 2021 through October 19, |
|
For the Fiscal Year Ended June 30, |
|
For the Fiscal Year Ended June 30, |
|
2022 |
|
2021 |
|
|
2021 |
|
2021 |
|
2020 |
North America |
|
|
|
|
|
|
|
|
|
|
Medical |
$ |
252.0 |
|
|
$ |
45.3 |
|
|
|
$ |
54.6 |
|
|
$ |
138.6 |
|
|
$ |
57.5 |
|
Industrial |
210.7 |
|
|
47.6 |
|
|
|
53.4 |
|
|
199.4 |
|
|
193.3 |
|
Total North America |
462.7 |
|
|
92.9 |
|
|
|
108.0 |
|
|
338.0 |
|
|
250.8 |
|
Europe |
|
|
|
|
|
|
|
|
|
|
Medical |
19.7 |
|
|
3.9 |
|
|
|
5.7 |
|
|
17.1 |
|
|
5.2 |
|
Industrial |
222.1 |
|
|
55.3 |
|
|
|
52.6 |
|
|
241.5 |
|
|
206.2 |
|
Total Europe |
241.8 |
|
|
59.2 |
|
|
|
58.3 |
|
|
258.6 |
|
|
211.4 |
|
Asia Pacific |
|
|
|
|
|
|
|
|
|
|
Medical |
— |
|
|
— |
|
|
|
— |
|
|
— |
|
|
— |
|
Industrial |
13.3 |
|
|
2.0 |
|
|
|
1.7 |
|
|
15.0 |
|
|
16.0 |
|
Total Asia Pacific |
13.3 |
|
|
2.0 |
|
|
|
1.7 |
|
|
15.0 |
|
|
16.0 |
|
Total Revenues |
$ |
717.8 |
|
|
$ |
154.1 |
|
|
|
$ |
168.0 |
|
|
$ |
611.6 |
|
|
$ |
478.2 |
|
|
Schedule of Revenue by Timing of Recognition |
The following details revenues by timing of recognition (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
Successor |
|
|
Predecessor |
|
Fiscal Year Ended December 31, |
|
From October 20, 2021 through December 31 |
|
|
From July 1, 2021 through October 19, |
|
For the Fiscal Year Ended June 30, |
|
For the Fiscal Year Ended June 30, |
|
2022 |
|
2021 |
|
|
2021 |
|
2021 |
|
2020 |
Point in time |
$ |
485.9 |
|
|
$ |
120.1 |
|
|
|
$ |
123.6 |
|
|
$ |
456.6 |
|
|
$ |
337.3 |
|
Over time |
231.9 |
|
|
34.0 |
|
|
|
44.4 |
|
|
155.0 |
|
|
140.9 |
|
Total Revenues |
$ |
717.8 |
|
|
$ |
154.1 |
|
|
|
$ |
168.0 |
|
|
$ |
611.6 |
|
|
$ |
478.2 |
|
|
Revenue from External Customers by Products and Services |
The following details revenues by product category (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
Successor |
|
|
Predecessor |
|
Fiscal Year Ended December 31, |
|
From October 20, 2021 through December 31 |
|
|
From July 1, 2021 through October 19, |
|
For the Fiscal Year Ended June 30, |
|
For the Fiscal Year Ended June 30, |
|
2022 |
|
2021 |
|
|
2021 |
|
2021 |
|
2020 |
Medical segment: |
|
|
|
|
|
|
|
|
|
|
Medical |
$ |
271.7 |
|
|
$ |
49.2 |
|
|
|
$ |
60.3 |
|
|
$ |
155.7 |
|
|
$ |
62.6 |
|
Industrial segment: |
|
|
|
|
|
|
|
|
|
|
Reactor Safety and Control Systems |
163.8 |
|
|
30.6 |
|
|
|
34.7 |
|
|
146.8 |
|
|
135.4 |
|
Radiological Search, Measurement, and Analysis Systems |
282.3 |
|
|
74.3 |
|
|
|
73.0 |
|
|
309.1 |
|
|
280.2 |
|
Total Revenues |
$ |
717.8 |
|
|
$ |
154.1 |
|
|
|
$ |
168.0 |
|
|
$ |
611.6 |
|
|
$ |
478.2 |
|
|
Schedule of Property, Plant, and Equipment by Geographical Areas |
The following details property, plant, and equipment, net by geography (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property, Plant, and Equipment, net |
|
Successor |
|
|
Predecessor |
(In millions) |
As of December 31, 2022 |
|
As of December 31, 2021 |
|
|
As of June 30, 2021 |
North America |
$ |
79.4 |
|
|
$ |
77.1 |
|
|
|
$ |
47.5 |
|
Europe |
44.7 |
|
|
46.7 |
|
|
|
41.1 |
|
Asia Pacific |
0.2 |
|
|
0.2 |
|
|
|
0.2 |
|
Total |
$ |
124.3 |
|
|
$ |
124.0 |
|
|
|
$ |
88.8 |
|
|